Skip to content

Assessment of Serum Levels of Adenosine Deaminase and Immunoglobulin E in Patients With Chronic Spontaneous Urticaria

Assessment of Serum Levels of Adenosine Deaminase and Immunoglobulin E in Patients With Chronic Spontaneous Urticaria

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05992987
Enrollment
90
Registered
2023-08-15
Start date
2023-08-15
Completion date
2024-03-31
Last updated
2023-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Spontaneous Urticaria

Keywords

chronic spontaneous urticaria, adenosine deaminase, immunoglobulin E

Brief summary

adenosine deaminase activity (ADA) has been reported to be elevated in various diseases such as psoriasis, acne and juvenile idiopathic arthritis. There is no previous studies that assessed ADA in chronic spontaneous urticaria (CSU) .

Interventions

DIAGNOSTIC_TESTAdenosine deaminase serum level

Adenosine deaminase will be measured by enzymatic (clorometric / kinetic) method (Diazyme laboratories, San Diego, California, USA).

DIAGNOSTIC_TESTIgE antibodies serum level

Level of IgE will be measured by electrochemiluminesence immunoassay (ECLIA, automatic cobase immunoassay, Roche Diagnostics GmbH, Mannheim, USA).

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* adult patients complaining of CSU and a group of age and sex-matched healthy controls (blood donors).

Exclusion criteria

* Pregnancy and lactation. * Patients with systemic diseases, especially those with autoimmune diseases and infections. * Patients with skin diseases. * Patients on medications such as antibiotics, nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, anticonvulsants, penicillin, and combined oral contraceptives.

Design outcomes

Primary

MeasureTime frameDescription
Serum level of adenosine deaminase3 monthsDifference in serum level of adenosine deaminase between CSU group and control group
Serum level of IgE3 monthsDifference in serum level of IgE between CSU group and control group

Contacts

Primary ContactAhmed M Ahmed, M.B.B.Ch
Dr.ahmed.elsheikh94@gmail.com+201093593974
Backup ContactRamadan Saleh, MD
salehr2010@yahoo.com+201005423054

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026